NanoMicS

NanoMicS is a proprietary nanoparticle drug delivery technology developed by SkyePharma, often in collaboration with partners like Chiron Corporation. The platform is specifically engineered to enhance the bioavailability of poorly water-soluble drugs, particularly for oral administration. By utilizing nanonization techniques to reduce the particle size of active pharmaceutical ingredients (APIs) to the nanometer range, NanoMicS increases the effective surface area, which significantly improves the dissolution rate and subsequent absorption in the gastrointestinal tract. The resulting nanoparticles are typically stabilized using a combination of surfactants and polymers to maintain their size and prevent aggregation during processing and storage.

Brand names

NanoMicS

Other names

NanoMicS technology